Jefferies Group LLC Alkermes Plc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Jefferies Group LLC holds 80 shares of ALKS stock, worth $2,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$2,520

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$22.0 - $31.87 $588,654 - $852,745	-26,757 Reduced 99.7%	80 $1,000
Q3 2022 Nov 14, 2022	SELL	$22.0 - $31.87 $138,028 - $199,952	-6,274 Reduced 53.16%	5,528 $1,000
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $416,460 - $481,768	-15,775 Reduced 57.2%	11,802 $164,000
Q1 2022 Sep 21, 2023	SELL	$23.07 - $27.99 $5.61 Million - $6.81 Million	-243,263 Reduced 90.06%	26,837 $706,000
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $150,462 - $182,550	-6,522 Reduced 19.13%	27,577 $707,000
Q4 2021 Feb 14, 2022	BUY	$21.47 - $32.08 $732,105 - $1.09 Million	34,099 New	34,099 $368,000
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $6.31 Million - $8.68 Million	-270,100 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$18.78 - $25.15 $4.97 Million - $6.65 Million	264,572 Added 4786.03%	270,100 $6.62 Million
Q2 2021 Aug 16, 2021	BUY	$18.78 - $25.15 $4.86 Million - $6.51 Million	258,698 Added 2268.88%	270,100 $6.62 Million
Q1 2020 May 15, 2020	SELL	$13.06 - $21.24 $1.76 Million - $2.87 Million	-134,953 Reduced 92.21%	11,402 $164,000
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $749,158 - $941,972	43,329 Added 42.06%	146,355 $2.99 Million
Q3 2019 Nov 13, 2019	BUY	$19.51 - $24.28 $769,181 - $957,239	39,425 Added 61.99%	103,026 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $1.37 Million - $2.37 Million	63,601 New	63,601 $1.43 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $683,218 - $877,839	-24,057 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$27.94 - $44.61 $739,264 - $1.18 Million	-26,459 Reduced 52.38%	24,057 $710,000
Q3 2018 Nov 14, 2018	BUY	$38.6 - $46.12 $1.37 Million - $1.64 Million	35,586 Added 238.35%	50,516 $2.14 Million
Q2 2018 Aug 14, 2018	BUY	$40.56 - $51.36 $605,560 - $766,804	14,930 New	14,930 $615,000
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $774,074 - $971,167	-14,439 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$47.69 - $55.39 $411,326 - $477,738	-8,625 Reduced 37.4%	14,439 $790,000
Q3 2017 Nov 14, 2017	BUY	$49.16 - $54.45 $1.13 Million - $1.26 Million	23,064	23,064 $1.17 Million

Others Institutions Holding ALKS

# of Institutions

393

Shares Held

176M

Call Options Held

558K

Put Options Held

427K

Black Rock Inc. New York, NY

29.1M
Shares

$917 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

18.5M
Shares

$583 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

10M
Shares

$316 Million
0.03% of portfolio
State Street Corp Boston, MA

8.21M
Shares

$259 Million
0.01% of portfolio
Baker Bros. Advisors LP New York, NY

6.41M
Shares

$202 Million
1.86% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.18B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account